SCHEMBL5506328

SCHEMBL5506328

CC1(C)O[C@@H]2[C@@H](O1)[C@H](n1cnc3c(NCC4CCCCC4)ncnc31)O[C@H]2C=O

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 1/20 0.46
PI4K2B Q8TCG2 1/20 0.46
PI4K2A Q9BTU6 1/20 0.46
PI4KB Q9UBF8 1/20 0.46
CCNA2 P20248 1/20 0.46
CDK2 P24941 1/20 0.46
CDK5 Q00535 1/20 0.46
CDK5R1 Q15078 1/20 0.46
ADORA3 P0DMS8 3/20 0.46
ADORA1 P30542 2/20 0.46
ADORA2A P29274 2/20 0.46
ADORA2B P29275 2/20 0.46
RXFP1 Q9HBX9 1/20 0.45
P2RX1 P51575 1/20 0.41
P2RX3 P56373 1/20 0.41
P2RX4 Q99571 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5504137 0.99 PI4KA (0.46) PI4KAPI4K2BPI4K2API4KBCCNA2
SCHEMBL5507611 0.91 PI4KA (0.43) PI4KAPI4K2BPI4K2API4KBCCNA2
SCHEMBL5507476 0.86 ADORA2A (0.56) ADORA3ADORA2AADORA2B
SCHEMBL5506455 0.86 PI4KA (0.64) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL5506522 0.85 ADORA2A (0.55) ADORA3ADORA1ADORA2AADORA2BRXFP1
SCHEMBL5996922 0.85 ADORA2A (0.55) ADORA3ADORA1ADORA2AADORA2BRXFP1
SCHEMBL5503630 0.85 ADORA2A (0.55) ADORA3ADORA1ADORA2AADORA2BRXFP1
SCHEMBL5510529 0.85 PI4KA (0.65) PI4KAPI4K2BPI4K2API4KBADORA3
SCHEMBL5512560 0.84 PI4KA (0.46) PI4KAPI4K2BPI4K2API4KBCCNA2
SCHEMBL5506216 0.84 ADORA2A (0.52) ADORA3ADORA1ADORA2AADORA2BRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537133-B1 PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS CV THERAPEUTICS INC (US) 2007-07-25 EP disclosed